Algert Global LLC Boosts Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Algert Global LLC grew its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 12.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 197,797 shares of the company’s stock after buying an additional 21,853 shares during the quarter. Algert Global LLC owned 0.11% of Option Care Health worth $5,479,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Parallel Advisors LLC increased its position in shares of Option Care Health by 130.2% in the fourth quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after buying an additional 478 shares in the last quarter. TFO Wealth Partners LLC increased its position in shares of Option Care Health by 24,625.0% during the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock worth $33,000 after purchasing an additional 985 shares in the last quarter. Park Place Capital Corp increased its position in shares of Option Care Health by 48.4% during the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after purchasing an additional 372 shares in the last quarter. Blue Trust Inc. increased its position in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares in the last quarter. Finally, SageView Advisory Group LLC purchased a new stake in shares of Option Care Health during the first quarter worth approximately $85,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Barrington Research boosted their price target on Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. JMP Securities assumed coverage on Option Care Health in a research report on Tuesday, July 16th. They set an “outperform” rating and a $36.00 price target for the company.

Option Care Health Stock Up 0.8 %

Shares of NASDAQ:OPCH opened at $31.42 on Monday. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. The business has a fifty day moving average of $31.29 and a two-hundred day moving average of $30.40. The stock has a market cap of $5.46 billion, a P/E ratio of 20.67, a PEG ratio of 2.42 and a beta of 1.29. Option Care Health, Inc. has a 52-week low of $26.11 and a 52-week high of $34.63.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.03. The company had revenue of $1.23 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The firm’s quarterly revenue was up 14.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.63 EPS. On average, research analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.